ask="N/A"
ask_size="N/A"
average_daily_volume="208352"
bid="2.80"
bid_size="300"
book_value="0.56"
change="-0.03"
change_from_200_day_moving_average="1.50"
change_from_50_day_moving_average="0.55"
change_from_52_week_high="-0.48"
change_From_52_week_low="2.16"
change_in_percent="-0.71%"
close="4.22"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.31"
ebitda="-5.76M"
eps_estimate_current_year="-0.30"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.91"
ex_dividend_date="N/A"
float_shares="16233000"
high="4.30"
high_52_weeks="4.70"
last_trade_date="3/16/2017"
last_trade_price="4.22"
last_trade_size="197"
last_trade_time="3:59pm"
low="4.16"
low_52_weeks="2.06"
market_capitalization="78.86M"
moving_average_200_day="2.72"
moving_average_50_day="3.67"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="6.00"
open="4.16"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+55.26%"
percent_change_from_50_day_moving_average="+14.90%"
percent_change_from_52_week_high="-10.21%"
percent_change_from_52_week_low="+104.84%"
previous_close="4.25"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.55"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="3.19"
stock_exchange="NCM"
symbol="BCLI"
volume="92212"
weeks_range_52="2.06 - 4.70"
